Catalyst Pharmaceuticals
CPRX
#3844
Rank
C$3.64 B
Marketcap
$30.56
Share price
-0.89%
Change (1 day)
43.16%
Change (1 year)

Earnings for Catalyst Pharmaceuticals (CPRX)

Earnings in 2024 (TTM): C$0.25 Billion

According to Catalyst Pharmaceuticals's latest financial reports the company's current earnings are C$0.46 Billion. In 2023 the company made an earning of C$0.13 Billion a decrease over its 2022 earnings that were of C$0.15 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Catalyst Pharmaceuticals from 2007 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) C$0.25 B87.79%
2023 C$0.13 B-9.75%
2022 C$0.15 B98.83%
2021 C$75.67 M25.73%
2020 C$60.18 M25.38%
2019 C$48 M-198.25%
2018 -C$48.86 Million84.68%
2017 -C$26.46 Million1.88%
2016 -C$25.97 Million-10.68%
2015 -C$29.08 Million30.46%
2014 -C$22.29 Million27.6%
2013 -C$17.47 Million198.17%
2012 -C$5.86 Million-36.22%
2011 -C$9.19 Million59.52%
2010 -C$5.76 Million-44.68%
2009 -C$10.41 Million-31.45%
2008 -C$15.18 Million155.21%
2007 -C$5.95 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
C$0.56 B 107.35%๐Ÿ‡บ๐Ÿ‡ธ USA
C$0.18 B-31.46%๐Ÿ‡บ๐Ÿ‡ธ USA
C$26.42 B 9,643.68%๐Ÿ‡บ๐Ÿ‡ธ USA
-C$0.4 Billion-243.96%๐Ÿ‡บ๐Ÿ‡ธ USA
C$9.97 B 3,577.65%๐Ÿ‡บ๐Ÿ‡ธ USA
C$9.73 B 3,490.25%๐Ÿ‡บ๐Ÿ‡ธ USA